Pre-eclampsia – Diagnostics – Overview of Information and Clinical Research

Pre-eclampsia is a serious pregnancy condition that usually appears after the 20th week, bringing high blood pressure and potential harm to vital organs—but many women don’t even know they have it until a routine check-up reveals the warning signs.

Introduction: Who Should Undergo Diagnostics and When

Pre-eclampsia is a condition that affects pregnant women, typically developing after 20 weeks of pregnancy or sometimes shortly after delivery. The challenge with this condition is that many women feel perfectly fine and have no idea anything is wrong. This is why regular prenatal appointments are so important—they serve as a crucial safety net to catch problems before they become dangerous.^[1]

Every pregnant woman should attend all scheduled prenatal visits, even when feeling healthy. During these appointments, healthcare providers routinely check blood pressure and test urine samples. These simple tests are the primary way pre-eclampsia is detected early. If you’re pregnant and notice symptoms like severe headaches that won’t go away, vision changes such as seeing flashing lights or blurry spots, sudden swelling in your face or hands, pain in the upper right side of your belly, or shortness of breath, you should contact your healthcare provider immediately or call emergency services.^[1]^[4]

Women with certain risk factors need even closer monitoring. If you have chronic high blood pressure, kidney disease, diabetes, or an autoimmune condition (a disorder where the body’s immune system mistakenly attacks its own tissues), your healthcare provider will watch you more carefully throughout pregnancy. The same applies if you’ve had pre-eclampsia in a previous pregnancy, if this is your first pregnancy, if you’re carrying twins or triplets, if you’re over 35 or under 18 years old, or if you have a family history of pre-eclampsia.^[3]^[5]

⚠️ Important

Pre-eclampsia can develop even after your baby is born, a condition called postpartum pre-eclampsia. This typically occurs within the first 48 hours after delivery but can happen up to six weeks later. Continue monitoring yourself for symptoms like severe headaches, vision problems, or sudden swelling even after childbirth, and report any concerns to your healthcare provider immediately.

Pre-eclampsia affects between 2% and 8% of all pregnancies worldwide. While most women with this condition deliver healthy babies and recover fully, the disease can progress quickly and become life-threatening for both mother and baby if not caught and managed properly. Globally, pre-eclampsia causes around 46,000 maternal deaths and approximately 500,000 fetal or newborn deaths each year.^[8]^[2]

The exact cause of pre-eclampsia remains unknown, though researchers believe it starts with problems in how the placenta (the organ that connects the baby’s blood supply to the mother’s) develops and attaches to the uterine wall. When the placenta doesn’t anchor deeply enough in the first trimester, it can lead to abnormal blood vessel development, which later affects blood flow throughout the mother’s body and reduces oxygen and nutrients reaching the baby.^[2]^[4]

Diagnostic Methods: How Pre-eclampsia Is Identified

Blood Pressure Measurement

The cornerstone of pre-eclampsia diagnosis is blood pressure monitoring. Blood pressure readings contain two numbers: the top number, called systolic pressure, measures the force against artery walls when your heart beats, while the bottom number, called diastolic pressure, measures the pressure when your heart rests between beats. Normal blood pressure is typically 120/80 millimeters of mercury (mmHg) or lower.^[9]

Pre-eclampsia is diagnosed when blood pressure reaches 140/90 mmHg or higher on at least two separate occasions, measured at least four hours apart, after the 20th week of pregnancy. If blood pressure is extremely high—160/110 mmHg or higher—healthcare providers may diagnose pre-eclampsia more quickly, sometimes within shorter intervals, because this level poses immediate danger. This severe range of high blood pressure requires urgent medical attention.^[2]^[9]

Because blood pressure can vary due to many factors including stress, activity level, or even the time of day, a single high reading doesn’t automatically mean pre-eclampsia. This is why healthcare providers take multiple measurements and why consistency matters. Some women are asked to monitor their blood pressure at home using special devices, which helps track patterns over time and catch concerning changes between appointments.^[3]

Urine Testing for Protein

Along with high blood pressure, the presence of protein in urine—called proteinuria—is a key diagnostic sign of pre-eclampsia. Normally, kidneys filter waste from blood while keeping protein inside blood vessels where it belongs. When pre-eclampsia affects the small blood vessels in the kidneys, they become “leaky” and allow protein to escape into the urine.^[1]^[8]

Healthcare providers test for protein in two main ways. During routine prenatal visits, they use a quick dipstick test—a small strip that changes color when dipped in a urine sample to indicate protein levels. If this screening test shows protein, more precise testing is needed. The most accurate method is collecting all urine produced over a 24-hour period and measuring the total protein content. A level of 0.3 grams or more in 24 hours indicates proteinuria consistent with pre-eclampsia.^[9]^[8]

However, it’s important to know that current medical guidelines recognize that pre-eclampsia can exist even without protein in the urine. Research has shown that serious organ problems involving kidneys and liver can occur without proteinuria, and the amount of protein doesn’t predict how severely the disease will progress. This means healthcare providers now look at the complete picture rather than relying solely on urine protein levels.^[12]

Blood Tests

Blood tests provide crucial information about how pre-eclampsia might be affecting different organs throughout the body. These tests help healthcare providers understand the severity of the condition and guide treatment decisions.

Liver function tests measure enzymes that leak into the bloodstream when liver cells are damaged. Elevated liver enzymes indicate that pre-eclampsia is affecting the liver. Similarly, kidney function tests measure substances like creatinine (a waste product normally filtered by kidneys) and check levels of uric acid in the blood. When these values are higher than normal, it signals that kidneys aren’t working properly.^[5]^[9]

Another important blood test checks platelet count. Platelets are tiny blood cells that help blood clot and stop bleeding. Pre-eclampsia can cause platelet levels to drop, a condition called thrombocytopenia, which increases bleeding risk. Low platelets combined with liver problems and breakdown of red blood cells creates a severe form of pre-eclampsia called HELLP syndrome, which stands for Hemolysis (red blood cell destruction), Elevated Liver enzymes, and Low Platelets.^[3]^[5]

These blood tests are typically repeated regularly throughout pregnancy if pre-eclampsia is diagnosed, allowing healthcare providers to monitor whether the condition is stable, improving, or getting worse. The frequency of testing depends on the severity of the condition—women with severe pre-eclampsia may need daily blood tests while hospitalized.^[9]

Assessment of Symptoms

Healthcare providers carefully evaluate any symptoms that might indicate pre-eclampsia is becoming severe. Severe headaches that don’t respond to pain medication can signal that pre-eclampsia is affecting blood vessels in the brain. Vision changes—including seeing spots, flashing lights, blurred vision, or sensitivity to light—occur when the condition affects blood flow to the eyes or the visual processing areas of the brain.^[1]^[4]

Pain in the upper right side of the abdomen, just below the ribs, can indicate liver swelling or damage. This pain might be confused with heartburn or stomach problems, but in the context of pregnancy after 20 weeks, it requires immediate medical evaluation. Sudden swelling, especially in the face and hands, suggests fluid is leaking from blood vessels into surrounding tissues. While some swelling in feet and ankles is normal during pregnancy, rapid swelling or swelling in unusual places is concerning.^[4]^[5]

Shortness of breath or difficulty breathing can mean fluid is accumulating in the lungs, a serious complication called pulmonary edema. Nausea and vomiting, particularly when they occur later in pregnancy rather than in early months, may signal severe pre-eclampsia. Healthcare providers take all these symptoms seriously because they indicate the condition is affecting vital organs and poses immediate danger.^[3]^[8]

Fetal Monitoring and Ultrasound

Because pre-eclampsia can affect blood flow through the placenta and reduce oxygen and nutrients reaching the baby, healthcare providers monitor the baby’s wellbeing closely. Ultrasound examinations allow doctors to see the baby’s growth and development, measure the amount of amniotic fluid (the liquid surrounding the baby in the womb), and check blood flow through the umbilical cord and placenta.^[9]

A nonstress test monitors the baby’s heart rate pattern. Healthy babies’ heart rates increase when they move. This test involves placing sensors on the mother’s belly to record the baby’s heartbeat over 20 to 40 minutes. A biophysical profile combines ultrasound with nonstress testing to evaluate the baby’s movements, breathing movements, muscle tone, and amniotic fluid volume. These tests help determine whether the baby is tolerating the pregnancy well or showing signs of distress that might require earlier delivery.^[13]

If pre-eclampsia reduces placental blood flow, babies may not grow as expected, a condition called fetal growth restriction. Serial ultrasounds measuring the baby’s size over time help detect this problem. Decreased amniotic fluid, called oligohydramnios, also indicates the placenta isn’t functioning optimally. These findings don’t diagnose pre-eclampsia in the mother but help healthcare providers understand how the condition is affecting the baby and decide the best timing for delivery.^[3]

Physical Examination

During physical examination, healthcare providers look for signs of complications. They check for swelling in the face, hands, feet, and ankles. While mild ankle swelling is common in normal pregnancy, especially later in the day, excessive or rapidly developing swelling throughout the body is abnormal. Doctors may check reflexes because hyperreflexia (exaggerated reflexes) can indicate the nervous system is being affected and seizures might be more likely.^[5]

Healthcare providers assess mental status and alertness, ask about vision changes, and evaluate pain in different areas of the abdomen. They listen to the lungs to detect any abnormal sounds that might indicate fluid accumulation. Weight is measured at each visit because sudden, rapid weight gain—more than two pounds in a week—often results from fluid retention and can signal worsening pre-eclampsia.^[5]

⚠️ Important

Pre-eclampsia can progress from mild to severe very quickly, sometimes within days or even hours. This unpredictability makes regular monitoring essential. If you’re diagnosed with pre-eclampsia, follow your healthcare provider’s recommendations for visit frequency closely, and don’t hesitate to seek care immediately if you notice any new or worsening symptoms between scheduled appointments.

Diagnostics for Clinical Trial Qualification

Clinical trials testing new treatments for pre-eclampsia use standardized diagnostic criteria to enroll participants. These criteria ensure that researchers are studying similar groups of women, which makes trial results more reliable and meaningful. Understanding these enrollment standards also helps explain how pre-eclampsia is formally defined in medical research.^[2]

For most pre-eclampsia clinical trials, women must meet specific blood pressure thresholds. Typically, this means systolic blood pressure of 140 mmHg or higher, or diastolic blood pressure of 90 mmHg or higher, measured on at least two occasions. The timing between measurements and the method used to measure blood pressure are carefully standardized. Some trials focus specifically on severe pre-eclampsia, requiring even higher blood pressure readings of 160/110 mmHg or higher.^[2]

Clinical trials may require documentation of proteinuria, though as understanding of pre-eclampsia has evolved, many trials now accept participants with signs of organ dysfunction even without protein in urine. Standard tests include the 24-hour urine collection showing 0.3 grams or more of protein, or a protein-to-creatinine ratio in a single urine sample that exceeds a certain threshold. This ratio compares the amount of protein to creatinine in the same urine sample, providing a quick alternative to 24-hour collection.^[12]

Trials enrolling women with pre-eclampsia with severe features require evidence of organ dysfunction through blood tests. This includes platelet counts below certain levels (typically less than 100,000 per microliter), liver enzyme levels elevated to more than twice the normal upper limit, kidney function tests showing creatinine levels above 1.1 milligrams per deciliter or doubling from baseline, or evidence of fluid in the lungs confirmed by chest examination or imaging.^[11]

The gestational age—how many weeks pregnant the woman is—matters for clinical trial enrollment. Since pre-eclampsia by definition occurs after 20 weeks of pregnancy, trials specify this minimum threshold. Some trials focus on early-onset pre-eclampsia (typically before 34 weeks) while others study late-onset disease (after 34 weeks) because these may represent slightly different conditions with different outcomes.^[2]

Clinical trials may also assess symptoms systematically using standardized questionnaires or scales. Participants might be asked to rate the severity of headaches, describe visual disturbances in specific terms, or report the location and intensity of abdominal pain. This standardization allows researchers to compare symptoms across participants and determine whether treatments improve specific problems.^[11]

Some research studies investigating prevention of pre-eclampsia enroll women before they develop the condition, selecting participants based on risk factors. These trials identify high-risk women through medical history (previous pre-eclampsia, chronic hypertension, diabetes, kidney disease, or autoimmune conditions) or use scoring systems that combine multiple risk factors to predict who is most likely to develop pre-eclampsia. Women identified as high-risk might then receive preventive interventions like low-dose aspirin and be monitored to see whether these treatments reduce pre-eclampsia occurrence.^[6]

Advanced research might include additional specialized tests beyond standard clinical care. Some trials measure levels of specific proteins or hormones in blood that may predict pre-eclampsia development or progression. For example, researchers have studied biomarkers like placental growth factor and soluble fms-like tyrosine kinase-1, proteins involved in blood vessel formation and function. While these tests aren’t routinely used in regular prenatal care yet, they help scientists better understand pre-eclampsia and might lead to improved diagnostic tools in the future.^[11]

Trials testing treatments to lower blood pressure in women with pre-eclampsia may require participants to have blood pressure in specific ranges—high enough to potentially benefit from medication but not so dangerously high that withholding treatment would be unethical. Safety protocols in these trials include frequent blood pressure monitoring, sometimes with home monitoring devices or wearable sensors that provide continuous data.^[13]

Women participating in pre-eclampsia clinical trials receive very close monitoring—often more frequent than standard prenatal care. This typically includes regular clinic visits for blood pressure checks, blood and urine tests, ultrasound examinations to monitor the baby’s growth and wellbeing, and assessments of symptoms. This intensive monitoring serves both to ensure participant safety and to collect detailed data about how pre-eclampsia progresses and responds to treatment.^[11]

Prognosis and Survival Rate

Prognosis

The outlook for women with pre-eclampsia varies considerably depending on several factors, including when during pregnancy the condition develops, how severe it becomes, and how quickly it’s diagnosed and managed. Most women with pre-eclampsia have healthy babies and recover completely after delivery. The condition typically resolves within the weeks following birth, as blood pressure returns to normal and organ function improves once the baby and placenta are delivered.^[4]^[10]

However, pre-eclampsia can cause serious short-term complications. Women may develop seizures (eclampsia), stroke, liver damage, kidney failure, blood clotting problems, or fluid in the lungs. The risk of these complications increases with severity of pre-eclampsia and delays in treatment. Early delivery of the baby prevents progression of severe disease, though premature birth creates challenges for newborns who haven’t finished developing.^[8]^[3]

The timing of pre-eclampsia onset affects prognosis. Women who develop the condition earlier in pregnancy, particularly before 34 weeks, face more difficult decisions because balancing the mother’s health against risks of premature delivery becomes more challenging. Babies born very prematurely due to severe pre-eclampsia may require intensive care and face higher risks of health problems. Women with pre-eclampsia that develops closer to full term typically have better outcomes for both mother and baby.^[2]

Pre-eclampsia also has important long-term health implications. Women who have had pre-eclampsia face at least twice the risk of developing cardiovascular disease later in life compared to women who had uncomplicated pregnancies. This includes increased risk of chronic high blood pressure, heart disease, stroke, and heart failure. Pre-eclampsia is now considered a significant risk factor that should trigger earlier and more frequent cardiovascular screening and preventive care throughout a woman’s lifetime.^[20]^[22]

The likelihood of pre-eclampsia recurring in future pregnancies is substantial. Women who had pre-eclampsia in one pregnancy have increased risk of developing it again. This risk is higher if pre-eclampsia occurred earlier in the previous pregnancy or was particularly severe. However, many women who had pre-eclampsia do go on to have subsequent pregnancies without complications, especially with close monitoring and preventive measures like low-dose aspirin.^[12]

Survival rate

In countries with well-resourced healthcare systems and access to comprehensive prenatal care, maternal death from pre-eclampsia is rare. Most women with pre-eclampsia survive and recover fully. However, pre-eclampsia remains a leading cause of maternal mortality worldwide, particularly in regions with limited access to medical care. Globally, approximately 46,000 maternal deaths occur each year due to pre-eclampsia and related conditions.^[8]

Pre-eclampsia and eclampsia account for approximately 10% of maternal deaths in Asia and Africa, and about 25% of maternal deaths in Latin America. These higher mortality rates in some regions reflect differences in access to prenatal care, availability of blood pressure monitoring and treatment, and ability to perform timely delivery when complications arise. Even simple interventions like magnesium sulfate to prevent seizures dramatically improve outcomes but remain underutilized in many low-resource settings.^[8]

In the United States, despite advanced medical care, maternal mortality has been increasing in recent years, and pre-eclampsia contributes to these deaths. Pre-eclampsia-related complications cause about 15% of premature deliveries in the United States. The condition affects between 5% and 8% of all births in the country, and mortality rates are significantly higher among African American women, who face more than twice the risk compared to white women.^[3]^[20]

Fetal and newborn survival is generally good when pre-eclampsia is detected and managed appropriately, though the condition contributes to an estimated 500,000 fetal or newborn deaths worldwide each year. Babies may be affected by reduced oxygen and nutrients if placental blood flow is compromised, or by complications of premature birth if early delivery becomes necessary. Intensive neonatal care has greatly improved survival rates for premature infants born due to severe pre-eclampsia, though these babies may face developmental challenges.^[8]

#1 Clinical Trials Search in Europe

Pre-eclampsia – Diagnostics

Introduction: Who Should Undergo Diagnostics and When